Pregnant women with antiphospholipid syndrome are at high risk of maternal
and fetal pregnancy complications. Multidisciplinary teams expert in this c
ondition should coordinate management. Even with current management strateg
ies, the risk of maternal thrombosis, fetal loss, or other adverse obstetri
c outcomes remains. Close monitoring of the various aspects of this conditi
on may reduce maternal morbidity and improve fetal outcome.